Brain Metastases: Biology and the Role of the Brain Microenvironment

Overview

Journal Curr Oncol Rep

Publisher Current Science

Specialty Oncology

Date 2001 Oct 12

PMID 11595114

Citations 13

Authors

V K Puduvalli

Affiliations

Soon will be listed here.

Abstract

Metastatic lesions constitute the most frequently occurring malignancy in the brain, and their detection portends a grim prognosis. Efforts to treat these lesions have failed partly because the biologic processes that govern their development are poorly understood. In recent years, it has become evident that metastases occur as a result of a multistep process involving a rigorous natural selection of cells in the primary tumor that bear molecular and biologic characteristics permitting brain metastasis. In addition, recent studies have uncovered the importance of the brain microenvironment and its contribution to the metastatic process. The development of targeted therapies against brain metastases demands a better understanding of these molecular processes and the factors that influence them. This review examines the interplay between tumor cells and host brain tissue in the context of our current understanding of the role of various molecules involved in the metastatic process.

Citing Articles

Significance of Trask protein interactions in brain metastatic cohorts of lung cancers.

Wu H, Shang L, Chen R, Yang S, Wang S, Wang J Tumour Biol. 2015; 36(6):4181-7.

PMID: 25775948 DOI: 10.1007/s13277-015-3053-7.

Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy.

Martinez-Aranda A, Hernandez V, Picon C, Modolell I, Sierra A Int J Mol Sci. 2013; 14(4):8306-27.

PMID: 23591844 PMC: 3645744. DOI: 10.3390/ijms14048306.

Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.

Lewis K, Harford-Wright E, Vink R, Ghabriel M Cancer Cell Int. 2013; 13(1):5.

PMID: 23374226 PMC: 3576291. DOI: 10.1186/1475-2867-13-5.

Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.

Louie E, Chen X, Coomes A, Ji K, Tsirka S, Chen E Oncogene. 2012; 32(35):4064-77.

PMID: 23001042 PMC: 3998718. DOI: 10.1038/onc.2012.417.

Neurosurgical treatment of breast cancer metastases to the neurocranium.

Stark A Patholog Res Int. 2011; 2011:549847.

PMID: 21209717 PMC: 3010687. DOI: 10.4061/2011/549847.

References

Brooks P, Clark R, Cheresh D . Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994; 264(5158):569-71. DOI: 10.1126/science.7512751. View

Saaristo A, Karpanen T, Alitalo K . Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene. 2001; 19(53):6122-9. DOI: 10.1038/sj.onc.1203969. View

Reyes-Reyes M, Mora N, Zentella A, Rosales C . Phosphatidylinositol 3-kinase mediates integrin-dependent NF-kappaB and MAPK activation through separate signaling pathways. J Cell Sci. 2001; 114(Pt 8):1579-89. DOI: 10.1242/jcs.114.8.1579. View

Diamond M, Springer T . The dynamic regulation of integrin adhesiveness. Curr Biol. 1994; 4(6):506-17. DOI: 10.1016/s0960-9822(00)00111-1. View

Aigner S, Sthoeger Z, Fogel M, Weber E, Zarn J, Ruppert M . CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood. 1997; 89(9):3385-95. View

Marchetti D . Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases. J Cell Physiol. 1997; 172(3):334-42. DOI: 10.1002/(SICI)1097-4652(199709)172:3<334::AID-JCP7>3.0.CO;2-P. View

Kawaguchi T, Kawaguchi M, Dulski K, Nicolson G . Cellular behavior of metastatic B16 melanoma in experimental blood-borne implantation and cerebral invasion. An electron microscopic study. Invasion Metastasis. 1985; 5(1):16-30. View

Sanderson R . Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 2001; 12(2):89-98. DOI: 10.1006/scdb.2000.0241. View

Cavallaro U, Christofori G . Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol. 2001; 50(1-2):63-70. DOI: 10.1023/a:1006414621286. View

10.

Marchetti D, Li J, Shen R . Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res. 2000; 60(17):4767-70. View

11.

Koop S, MacDonald I, Luzzi K, Schmidt E, Morris V, Grattan M . Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res. 1995; 55(12):2520-3. View

12.

Bouton A . PKC-dependent activation of FAK and src induces tyrosine phosphorylation of Cas and formation of Cas-Crk complexes. Exp Cell Res. 2001; 264(2):296-306. DOI: 10.1006/excr.2000.5137. View

13.

Stetler-Stevenson W, Yu A . Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol. 2001; 11(2):143-52. DOI: 10.1006/scbi.2000.0365. View

14.

Attwell S, Roskelley C, Dedhar S . The integrin-linked kinase (ILK) suppresses anoikis. Oncogene. 2000; 19(33):3811-5. DOI: 10.1038/sj.onc.1203711. View

15.

Herrmann J, Menter D, Hamada J, Marchetti D, Nakajima M, Nicolson G . Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell. 1993; 4(11):1205-16. PMC: 275754. DOI: 10.1091/mbc.4.11.1205. View

16.

Glinsky G, Glinsky V . Apoptosis amd metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett. 1996; 101(1):43-51. DOI: 10.1016/0304-3835(96)04112-2. View

17.

Santambrogio L, Belyanskaya S, Fischer F, Cipriani B, Brosnan C, Ricciardi-Castagnoli P . Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A. 2001; 98(11):6295-300. PMC: 33462. DOI: 10.1073/pnas.111152498. View

18.

Drewes L . What is the blood-brain barrier? A molecular perspective. Cerebral vascular biology. Adv Exp Med Biol. 2000; 474:111-22. DOI: 10.1007/978-1-4615-4711-2_10. View

19.

Cao Y . Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol. 2001; 33(4):357-69. DOI: 10.1016/s1357-2725(01)00023-1. View

20.

Felding-Habermann B, HABERMANN R, Saldivar E, Ruggeri Z . Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem. 1996; 271(10):5892-900. DOI: 10.1074/jbc.271.10.5892. View